![]() While GLP-1RAs effectively improve glycemic control and cause weight loss, potential safety concerns have arisen over the years. The glucagon-like peptide-1 receptor agonist (GLP-1RA) semaglutide is the most recently approved agent of this drug class, and the only GLP-1RA currently available as both subcutaneous and oral formulation.
0 Comments
Leave a Reply. |